Petros Pharmaceuticals's total assets for Q1 2026 were $4.39M, a decrease of -99.91% from the previous quarter. PTPI total liabilities were $2.62M for the fiscal quarter, a -99.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.